Barclays’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6
Closed -$22K 4983
2021
Q3
$22K Sell
6
-2,449,972
-100% -$450M ﹤0.01% 4366
2021
Q2
$450M Sell
2,449,978
-1,128,398
-32% -$194M 0.37% 65
2021
Q1
$547M Buy
3,578,376
+3,212,242
+877% +$497M 0.53% 44
2020
Q4
$57.2M Sell
366,134
-42,407
-10% -$5.45M 0.06% 422
2020
Q3
$46.8M Buy
408,541
+172,430
+73% +$18.6M 0.06% 415
2020
Q2
$26.5M Sell
236,111
-149,218
-39% -$15.8M 0.04% 534
2020
Q1
$34.6M Sell
385,329
-99,558
-21% -$9.77M 0.06% 425
2019
Q4
$52.4M Sell
484,887
-103,943
-18% -$11.1M 0.06% 489
2019
Q3
$57.7M Buy
588,830
+209,233
+55% +$23.6M 0.07% 408
2019
Q2
$49.7M Buy
379,597
+112,799
+42% +$14.5M 0.06% 490
2019
Q1
$36.1M Sell
266,798
-124,020
-32% -$15.4M 0.05% 552
2018
Q4
$38M Sell
390,818
-80,780
-17% -$9.55M 0.06% 473
2018
Q3
$65.6M Buy
471,598
+177,468
+60% +$22.3M 0.1% 318
2018
Q2
$36.5M Sell
294,130
-312,897
-52% -$36.6M 0.06% 479
2018
Q1
$67.7M Buy
607,027
+32,039
+6% +$3.83M 0.1% 319
2017
Q4
$68.8M Sell
574,988
-59,099
-9% -$7.2M 0.11% 292
2017
Q3
$89M Sell
634,087
-214,964
-25% -$29.2M 0.21% 175
2017
Q2
$103M Buy
849,051
+589,735
+227% +$68.6M 0.24% 138
2017
Q1
$31.4M Buy
259,316
+95,536
+58% +$12.3M 0.07% 386
2016
Q4
$20M Buy
163,780
+51,137
+45% +$6.26M 0.06% 595
2016
Q3
$13.8M Sell
112,643
-58,004
-34% -$7.47M 0.04% 697
2016
Q2
$19.9M Buy
170,647
+68,955
+68% +$9.78M 0.07% 525
2016
Q1
$14.1M Sell
101,692
-129,527
-56% -$19M 0.05% 610
2015
Q4
$43.9M Buy
231,219
+72,209
+45% +$12.6M 0.13% 316
2015
Q3
$24.8M Sell
159,010
-417,052
-72% -$76.1M 0.07% 499
2015
Q2
$104M Buy
576,062
+359,783
+166% +$62.1M 0.24% 141
2015
Q1
$37.4M Sell
216,279
-3,289
-1% -$595K 0.08% 413
2014
Q4
$40.6M Buy
219,568
+8,165
+4% +$1.51M 0.07% 421
2014
Q3
$34.9M Buy
211,403
+18,275
+9% +$3M 0.07% 461
2014
Q2
$30.1M Sell
193,128
-9,737
-5% -$1.54M 0.06% 497
2014
Q1
$30.8M Sell
202,865
-79,346
-28% -$12.6M 0.06% 478
2013
Q4
$37.3M Buy
282,211
+17,600
+7% +$2.11M 0.07% 456
2013
Q3
$30.7M Buy
264,611
+98,559
+59% +$10.8M 0.07% 468
2013
Q2
$15.3M Buy
+166,052
New +$16M 0.04% 793

Other funds holding ALXN